|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 51/10 | |
| A61K 39/00 | |||
| A61K 47/68 | |||
| C07K 16/28 | |||
| C07K 16/30 | |||
| C12N 15/115 |
| (11) | Number of the document | 3020730 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15197139.7 |
| Date of filing the European patent application | 2012-01-19 | |
| (97) | Date of publication of the European application | 2016-05-18 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161434040 P | 2011-01-19 | US |
| (72) |
Fioretos, Thoas, SE
Järås, Marcus, SE
|
| (73) |
Cantargia AB,
Medicon Village Scheelevägen 2, 223 81 Lund,
SE
|
| (54) | ANTI-IL1RAP ANTIBODIES AND THEIR USE FOR TREATING SOLID TUMOURS |
| ANTI-IL1RAP ANTIBODIES AND THEIR USE FOR TREATING SOLID TUMOURS |